A part owner of a compounding pharmacy in Maitland has agreed to pay the federal government $7.75 million to resolve fraud allegations.
Andy Miller, Tracy Miller and the Healthmark Investment Trust agreed to the settlement over allegations that QMedRx knowingly billed federal health care programs for services that were not reimbursable, according to a press release from the U.S. Department of Justice.
From Jan. 1, 2013, until Jan. 22, 2014, QMedRx submitted for reimbursement compounded prescriptions that were tainted within the meaning of the Anti-Kickback Statute. Because Healthmark In...
Comments